Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
AKR1C3 overexpression
Cancer:
Breast Cancer
Drug:
tamoxifen
(
Estrogen receptor antagonist
)
Direction:
Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Source:
BMC Cancer
Title:
The role of AKR1 family in tamoxifen resistant invasive lobular breast cancer based on data mining
Published date:
12/09/2021
Excerpt:
Compared with TAM-sensitive counterparts, the expression levels of AKR1C1, AKR1C2, and AKR1C3 were up-regulated in TAM-resistant breast cancer cells.
DOI:
10.1186/s12885-021-09040-8
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login